Abstract
We investigated noninvasive procedures by hybrid imaging to assess the sites of active or inactive hematopoiesis in patients with primary myelofibrosis (PMF). To this end, we used two radionuclides, technetium 99m (99mTc) and indium 111-chloride (111In-Cl3), coupled with single-photon emission tomography/computed tomography (SPECT/CT). We studied five patients with PMF and one with secondary myelofibrosis (MF). The classical pattern of lower fixation of both tracers at the axial skeleton where the myelofibrotic process occurs and the reactivation of sites of active hematopoiesis at the distal skeleton were confirmed. Coupling both radionuclides to SPECT/CT imaging allowed for more precise visualization of the sites of extramedullary hematopoiesis as those observed in the spleen and liver. Splenic high uptake of 111In-Cl3 coupled with SPECT/CT represents a pathognomonic feature of PMF. We conclude that, the hybrid imaging procedures that we studied might constitute an alternative noninvasive method for the screening of the whole-body marrow and, by this way, to assess the impact of targeted therapies in PMF patients in whom it is well known that the distribution of the hematopoietic active areas is disturbed. Hybrid imaging could also be useful for diagnostic purposes in cases of early PMF or in suspected cases of myelofibrosis secondary to polycythemia vera or essential thrombocythemia.
Hybrid imaging procedures coupling radionuclides to single-photon emission tomography/computed tomography allow a good evaluation of the extent and intensity of the sites of active/inactive hematopoiesis in primary or secondary myelofibrosis patients. This procedure can also be useful in challenging differential diagnosis cases of myeloproliferative neoplasms or when a myelofibrotic transformation of essential thrombocytemia or polycythemia vera is suspected.
from Cancer via ola Kala on Inoreader http://ift.tt/2aQBaPG
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου